Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Amino acid transporter heavy chain SLC3A2 (also known as CD98hc or 4F2hc) is a type II transmembrane glycoprotein that plays a critical role in cellular metabolism and integrin-dependent signaling. It functions primarily as a chaperone, forming disulfide-linked heterodimers with various light chains of the SLC7 family (such as LAT1, LAT2, and xCT) to facilitate their trafficking to the plasma membrane and stabilize their amino acid transport activity. Beyond its role in nutrient uptake, SLC3A2 interacts with integrins to regulate cell adhesion, migration, survival, and proliferation. It is highly overexpressed in numerous hematological and solid malignancies, including acute myeloid leukemia (AML), non-small cell lung cancer (NSCLC), and head and neck squamous cell carcinoma (HNSCC), where it supports the high metabolic demands of rapidly dividing tumor cells. Consequently, SLC3A2 has emerged as a promising therapeutic target, with monoclonal antibodies (such as IGN523 and KHK2898), antibody-drug conjugates (ADCs), and CAR-T therapies being developed to inhibit its transport function, disrupt integrin signaling, and induce antibody-dependent cellular cytotoxicity (ADCC).
Antibody-dependent cellular cytotoxicity (ADCC), inhibition of amino acid transport, lysosomal membrane permeabilization, apoptosis induction, and disruption of heterodimeric transporter complexes
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Amino acid transporter heavy chain SLC3A2 (SLC3A2).